Page last updated: 2024-12-08
desethyl-n-acetylprocainamide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
desethyl-N-acetylprocainamide: metabolite of acetylprocainamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 155689 |
| SCHEMBL ID | 8101162 |
| MeSH ID | M0091653 |
Synonyms (10)
| Synonym |
|---|
| denapa |
| benzamide, 4-(acetylamino)-n-(2-(ethylamino)ethyl)- |
| 72040-49-4 |
| deethylacecainide |
| deethyl-n-acetylprocainamide |
| desethyl-n-acetylprocainamide |
| SCHEMBL8101162 |
| DTXSID30222354 |
| JNDZQWRVBINENC-UHFFFAOYSA-N |
| desethyl-n-acetyl procainamide |
Research Excerpts
Pharmacokinetics
| Excerpt | Reference | Relevance |
|---|---|---|
| " Acecainide renal clearance, nonrenal clearance, steady-state volume of distribution, and other pharmacokinetic parameters were estimated using standard approaches." | ( Acecainide pharmacokinetics in normal subjects of known acetylator phenotype. Boudoulas, H; Coyle, JD; Lima, JJ, 1991) | 0.28 |
| "The pharmacokinetic profile and the cardiovascular actions of desethyl-N-acetylprocainamide (NAPADE) were studied in chloralose-urethane anesthetized dogs." | ( Cardiovascular actions and pharmacokinetics of desethyl-N-acetylprocainamide in the dog. King, LW; Lertora, JJ, 1986) | 0.77 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.51
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||